DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
DCPH
Delisted
DCPH was delisted on the 10th of June, 2024.
153 hedge funds and large institutions have $2.22B invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 63 increasing their positions, 35 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
25% more funds holding
Funds holding: 122 → 153 (+31)
25% more call options, than puts
Call options by funds: $62.3M | Put options by funds: $49.8M
Holders
153
Holding in Top 10
6
Calls
$62.3M
Puts
$49.8M
Top Buyers
| 1 | +$97.3M | |
| 2 | +$75.7M | |
| 3 | +$47.2M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$47.1M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
+$31.1M |
Top Sellers
| 1 | -$164M | |
| 2 | -$61.5M | |
| 3 | -$58.9M | |
| 4 |
Alkeon Capital Management
New York
|
-$26.9M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
-$24.1M |